Search research articles
Contact Us
Filters
Showing results (201-210 of 241) with videos related to
Page
of 25
Sort By:
Journal of Virology
|
April 13, 2018
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs
Christine A Bricault, James M Kovacs, Alexander Badamchi-Zadeh, et al.
Open Forum Infectious Diseases
|
November 12, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology
Jaspreet Banga, Taylor Brock-Fisher, Brittany A Petros, et al.
Frontiers in Immunology
|
April 10, 2026
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures
Andrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 19, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology
Jaspreet Banga, Taylor Brock-Fisher, Brittany A Petros, et al.
Journal of Water and Health
|
September 27, 2023
Rapidly developed, optimized, and applied wastewater surveillance system for real-time monitoring of low-incidence, high-impact MPOX outbreak
Chandler H Wong, Zhihao Zhang, Walaa Eid, et al.
Annals of Internal Medicine
|
February 15, 2021
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine
Nadine C Salisch, Kathryn E Stephenson, Kristi Williams, et al.
Annals of Internal Medicine
|
April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)
Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
Cell Reports
|
December 16, 2020
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound
Rasmus Offersen, Wen-Han Yu, Eileen P Scully, et al.
Nature
|
November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H Barouch, James B Whitney, Brian Moldt, et al.
Nature Medicine
|
September 12, 2024
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial
Boris Julg, Victoria E K Walker-Sperling, Kshitij Wagh, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 241) with videos related to
Sort By:
Page
of 25
Journal of Virology
|
April 13, 2018
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs
Christine A Bricault, James M Kovacs, Alexander Badamchi-Zadeh, et al.
Open Forum Infectious Diseases
|
November 12, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology
Jaspreet Banga, Taylor Brock-Fisher, Brittany A Petros, et al.
Frontiers in Immunology
|
April 10, 2026
Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures
Andrew Fiore-Gartland, Koshlan Mayer-Blackwell, James Stray, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 19, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology
Jaspreet Banga, Taylor Brock-Fisher, Brittany A Petros, et al.
Journal of Water and Health
|
September 27, 2023
Rapidly developed, optimized, and applied wastewater surveillance system for real-time monitoring of low-incidence, high-impact MPOX outbreak
Chandler H Wong, Zhihao Zhang, Walaa Eid, et al.
Annals of Internal Medicine
|
February 15, 2021
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine
Nadine C Salisch, Kathryn E Stephenson, Kristi Williams, et al.
Annals of Internal Medicine
|
April 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)
Sharon A Riddler, Zoe Moodie, Jesse Clark, et al.
Cell Reports
|
December 16, 2020
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound
Rasmus Offersen, Wen-Han Yu, Eileen P Scully, et al.
Nature
|
November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H Barouch, James B Whitney, Brian Moldt, et al.
Nature Medicine
|
September 12, 2024
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial
Boris Julg, Victoria E K Walker-Sperling, Kshitij Wagh, et al.
Page
of 25